With new data, Regenxbio to seek FDA approval of Duchenne gene therapy BioPharma Dive 15:32 Thu, 14 May
STAT Plus: Pharmalittle: We’re reading about upbeat results for a Duchenne drug, Takeda layoffs, and much more STAT 14:54 Thu, 14 May
REGENXBIO Announces Positive Topline Results from Pivotal Phase III AFFINITY DUCHENNE® Study of RGX-202 PR Newswire (Press Release) 12:05 Thu, 14 May
STAT Plus: Regenxbio says Duchenne gene therapy succeeded in clinical trial, paving way for FDA submission STAT 12:02 Thu, 14 May
Duchenne syndrome parents spend night of 22nd outside Chancellery, demand medicine Georgia Today 10:48 Tue, 12 May
STAT Plus: Capricor Therapeutics accuses Nippon Shinyaku of slow-walking plans on Duchenne drug STAT 20:02 Fri, 08 May
Capricor Therapeutics Says NS Pharma Delays Could Threaten Access To Duchenne Therapy Benzinga 14:40 Fri, 08 May Article paywall
Georgia expands medical services for children with Duchenne and rare diseases Georgia Today 14:23 Thu, 07 May
Parents of Duchenne muscular dystrophy children spend 17th night at government office Georgia Today 10:08 Thu, 07 May
REGENXBIO to Host Webcast on May 14 to Discuss Topline Results from Pivotal Trial of RGX-202 for Duchenne Muscular Dystrophy PR Newswire (Press Release) 12:12 Wed, 06 May
Clinical Trial Begins for PBGENE-DMD, Duchenne Muscular Dystrophy Gene Editing Therapy Rare Disease Advisor 16:07 Tue, 05 May
Kobakhidze: ‘pharmaceutical mafia’ interests must be considered in Duchenne drug decision Georgia Today 12:26 Tue, 05 May
Fake accounts involved in campaign against Duchenne muscular dystrophy drugs in Georgia — Myth Detector JAM-news 14:29 Thu, 30 Apr
Parents of Duchenne patients appeal to Prosecutor’s Office over police actions Georgia Today 09:50 Tue, 28 Apr
Capricor Highlights Hope-3 Data Showing Functional Gains In Duchenne Muscular Dystrophy RTT News 11:23 Thu, 23 Apr
Opinion: 'Funding treatment for Duchenne muscular dystrophy in Georgia is a matter of priorities' JAM-news 14:16 Tue, 21 Apr
Parents of Duchenne children continue protest over access to medication Georgia Today 08:35 Tue, 21 Apr
Roche launches global Phase III Elevidys trial to support EU approval for Duchenne gene therapy Manufacturing Chemist 12:27 Fri, 17 Apr
Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy FiercePharma 15:12 Thu, 16 Apr
